Background
==========

Protease-activated receptor-2 (PAR-2) is a G-protein-coupled receptor recognized to mediate inflammatory responses. Using a PAR-2 \'knockout\' mouse, we previously demonstrated this receptor to play a crucial role in chronic joint inflammation \[[@B1]\]. Inhibition of PAR-2 activation therefore potentially represents a novel therapeutic target in treatment of arthritis, but selective antagonists are not yet available.

Objective
=========

To test the hypothesis that acute joint inflammation could be inhibited by targeting the \'tethered ligand\' sequence of PAR-2 using a specific monoclonal antibody (SAM-11).

Methods
=======

The presence of synovial PAR-2 was confirmed in wild-type (PAR-2^+/+^) C57BL/6J mice by western blotting using SAM-11 (Santa Cruz, USA). The anti-inflammatory potential of this antibody, which inhibits PAR-2 activation by preventing release of its activating ligand, was investigated by intra-articular administration of SAM-11 to mice prior to induction of acute joint inflammation (under halothane/O~2~/N~2~O anaesthesia) by injection of 20 μl 2% carrageenan and 4% kaolin (C/K) into the knee joint. Joint swelling was assessed by comparing caliper-measured knee joint diameter pre and 24 hours post-injection. The swelling response was compared in untreated, and in two parallel groups of inflamed mice that had received intra-articular injection of SAM-11 at 5 ng or 10 ng, 5 min prior to C/K administration. Selectivity of SAM-11 for PAR-2 was confirmed by immunohistochemical analysis (in combination with the Animal Research Kit Dako, USA) of the wild-type mouse brain, which expresses PAR-1, PAR-2, PAR-3 and PAR-4 compared with that of PAR-2 gene-disrupted (PAR-2^-/-^) mice.

Results
=======

Western blotting demonstrated the presence of PAR-2 in normal murine synovium and substantial upregulation in acutely inflamed joints. Immunohistochemical analysis of the murine brain with SAM-11 revealed staining in PAR-2^+/+^mice but not in PAR-2^-/-^mice, confirming PAR-2 specificity of this monoclonal antibody. C/K resulted in substantial knee joint swelling, which was significantly and dose-dependently (*P*\< 0.00001; one-way analysis of variance; *n*= 4 per group) inhibited by SAM-11 pretreatment (Fig. [1](#F1){ref-type="fig"}). These findings are consistent with a proinflammatory role for PAR-2 in arthritis, and demonstrate that antibody inhibition of PAR-2 activation ameliorates acute joint inflammation.

![Twenty-four hours after intra-articular injection of kaolin, knee joint swelling is dose-dependently reduced by SAM-11 pre-treatment. \*\* *P*\< 0.00001, \* *P*\< 0.01 (*n*= 4 per group). NS, no significantly.](ar1681-1){#F1}
